The facts are I was predicting .30 when I was led to believe by Gerald that we'd have the LymPro numbers in August followed by a partnership announcement instead of what actually happened or I should say didn't happen accompanied by the addition of another one billion shares.

I admit it was foolish of me to place so much faith in Gerald accomplishing what he conveyed to the market and the shareholders. Any perceived deception falls squarely on Gerald.

As to my change in sentiment it's easy to go back and see when it occurred and you'll find it's timed with the aforementioned events.

Anyone who didn't anticipate how the market would view Gerald's failure to deliver and the resultant decrease in the share price only has themselves to blame for the subsequent decline in the value of their AMBS investment.

A reverse split is irrelevant here because I think it's at least six months away.

If I'm correct you'll be able to buy share below .065 next week which should make you very happy as you obviously think they would be substantially undervalued at that price.

Varying opinions is what creates a market.

Typically penny stocks drop a minimum of 30% when dilution occurs in-line with what is about to happen on Monday. If you think .09 is a good entry price then you'll think anything below .07 will be a gift.

Unless Gerald has some substantial news on Monday I think the share price will go below .06 by next Friday assuming the additional one billion shares are approved.

There's going to be a number of "beached whales" wishing they'd taken some profits off the table.

p.s. Anyone attending the shareholder's meeting may want to ask Gerald about the 154M shares for the 2014 Stock Plan. Considering his efforts to minimize dilution the number of shares is way out of line.

Expecting substantial volatility through next week as the the market searches for a bottom.

I'm thinking a worse case scenario puts it in the .06 - .065 range which actually may not happen until the latter part of the month.

Some individuals have suggested .03 - .04 as a possible bottom but I think that's too low.

One of the problems in getting the stock to move higher is that there are substantially more individuals trying to flip the stock for 5-10% gains and there are a lot of shares held at higher prices where many individuals are just hoping to get back to break even so they can sell.

I also think that the expectations of many individuals of 300-500% returns in a matter of a few months are now tempered by reality.

Who would have thought three months ago that the share price would hit .083 today and another 1,000,000,000 shares will be added in a few days. How about those 153M shares for the 2014 Stock Plan.

At one point he was given some degree of credibility but I think that has changed:

fibonacci @fibonacci1170

$AMBS Multivariate data release in Q1 2015. Management unanimous in Q4 2014 uplist at $8, w/ new shares+RS. Could test 3-4 cents.

Thanks for pointing that out.

Foolish of someone to buy so many shares at .089 when they'll be able to buy them below .07 next week.

Below .07 next week.

Watch and learn.

Stays below a dime until 1Q2015.

I'm thinking it will be bought out at several times the current price.

I purchased a position which is about 5% of my portfolio and will just hold and see what develops.

"Patience is a virtue."

p.s. I do think it's one of the most undervalued bio-techs in the market.

I'm convinced that Gerald could care less about the retail investor except for the fact that he needs them to create a market for the stock. His primary objective is to keep the doors open.

I can see substantial dilution occurring for several years. I do think the company will succeed but I also think the current shareholders will get hurt by the continued dilution.

The current whales are going to be reduced to minnows as the dilution continues in the coming years.

Just saying!!!

p.s. Back to a nickle before the end of the year?

Sometimes it takes a little bit of common sense to see what is about to happen to the share price with another one billion shares being added.

Posting about butterflies, puppies, and the pot of gold at the end of the rainbow while being happy thoughts ignores the realities of the penny stock market.

BioLineRx Presents Positive Preclinical Results in Treatment for AML Patients with FLT3 Mutations

http://finance.yahoo.com/news/biolinerx-presents-positive-preclinical-results-110000912.html

Appears to me that the six month chart indicates a "head and shoulders" formation with a move back to the .068 range which occurred in mid April.

http://finance.yahoo.com/echarts?s=AMBS+Interactive

With another billion shares on the way it will be interesting to see the market's reaction especially if there is not any substantial positive news next week.

Interesting weeks ahead.

$8.00 Price Target from Roth Capital seems reasonable.

http://www.smarteranalyst.com/2014/08/21/biolinerx-we-see-significant-potential-upside-in-this-name-says-roth-capital/

Gerald's first obligation as C.E.O. is to insure the company has the funds it needs to continue in operation. If he needs to sell additional shares to L.P.C. for as little as four cents a share to obtain operating funds I'm certain that he will do it if there is no better option available to him.

It's not uncommon that the initial investors in small cap bio-techs get diluted to the point of being irrelevant in the long term. I think that's why it's a necessity to take advantages of spikes in the share price to pull some profits off the table and re-buy at a lower price as a counter measure to the future dilution.

Interesting weeks ahead.

Although the share price could go lower during expected trading volatility after the additional one billion shares are announced I'm expecting the share price to firm up in the .072 range by October 1.

Much depends on what the S & S numbers for LymPro will be.

Interesting three weeks ahead.

My scenario makes perfect sense.

L.P.C. main goal is to maximize profits. The more shares of AMBS that they can obtain for their future investment of $18M the better the opportunity to maximize profits in the long run especially if they can make money initially shorting the stock and then buying at the low to cover and ride the share price higher.

That would be my approach and I know very little about such things.

If you take the time to research some of Lincoln Park Capital's investments over the last three years you will find that in over 80% of the companies that the share price is lower one year later than it was at the time of the investment.

There has been a number of references to L.P.C.'s "affiliates" which would refer to companies that are related to L.P.C. that could work with it to trade the stocks of the companies in which L.P.C. has invested without violating the provisions of any agreements that L.P.C. has with those companies.

I would think that it would make perfect sense for L.P.C. to shorts AMBS shares through its affiliates knowing that when the company faces a cash crunch at the end of the year that L.P.C. can purchase shares as low as four cents.

L.P.C. number one objective is to maximize the return on its investment. One way of doing this is to maximize the number of AMBS shares it obtains for its $18,000,000.

Obviously this is speculation but in the land of penny stocks it makes perfect sense.

After spending several hours on due diligence this weekend I purchased my first shares of BLRX today at $1.62.

I'm very impressed with the company's management team, product pipeline, financial situation, and low market cap. Substantial upside with the potential as a takeover target by "big pharma".

If anyone is interested the following is a very good source of information:

http://www.biolinerx.com/uploaded/Company%20presentation%20%28Sep-14%29.pdf

Does anyone know what impact doubling the number of shares to two billion will have on the financing agreement with Lincoln Park Capital?

I know they can't buy shares for less than four cents. I wonder if L.P.C. can opt out of the agreement due to the substantial increase in the share count. I would think that the four cent price was put in because the increase had already been planned months ago.

If the share price drops to the .06 range then L.P.C.'s $18M could get them 300M shares. Who thinks Gerald won't need a good portion of the additional one billion shares to raise cash?

154M shares go to the 2014 Stock Plan.

It wouldn't take much to use up the one billion shares.

I thought it would be there also until Gerald made several major blunders.

Now the market has to contend with the increase in the share count to two billion. Major dilution is always a concern with penny stocks.

Will you be buying shares when the share price is below .08 next week?

You have to admit that you never thought you'd see two billion shares at this point in time if ever.

I haven't seen any reference to the 153,880,168 shares for the 2014 Stock Plan that the shareholder's are being asked to approve.

More free shares for Gerald, his father, and other members of the AMBS team.

I guess these shares don't count towards future dilution.

I think the share price bottoms at .072 although it could go lower with an overall market correction of 20% before the end of the year.

Over the two days from when the actual filing is announced which details that the number of authorized shares have been increased to 2 billion I expect the share price will drop a minimum of 20%.

The drop from 19.8 to 9.3 was interesting but I'm thinking a drop from .097 to .072 lies ahead.

We'll know soon enough.

p.s. I think the "Big One" is lurking ahead.

If anyone wants to buy a million shares for .13 on Monday please put in a limit order, AON, at .13 for 1,000,000 shares and it will get filled.

You're welcome.

Stay tuned. The next three weeks should be very interesting if you like volatility.

I know I'm looking forward to it.

Everyone should be so fortunate to be as desperate as I am.

You spend way too much time focused on me. Instead of using more of your valuable time replying to this post why don't you put it to a more constructive use.

In fact why don't you follow your own advice, "New comers, dont listen to anybody, myself included. Buy, sell or hold based on your own dd. Most advices here are bogus. You are advised..."

I'll have the opportunity to buy shares below .09 after the shareholder's meeting on 9/21.

Have a great weekend!!! I'll be back on Monday morning.

p.s. I still don't know why anyone would think I have any ability to influence the share price. Occasionally I do stop the share price from going lower with a large buy order.

"eventually increase shareholder value".......

Let's hope it's before he goes through another billion shares.

I guess I'll have to be content with my million shares for now.

Let it go. Four cents is the lowest price that LPC can purchase shares if the market price goes that low and the company wants to sell them.

It's foolish of you to argue a point on which you are obviously wrong.

Definitely hurts your credibility on other items that might be of greater importance.

E-mail Gerald and ask him.

Gerald - who's that?

He couldn't even get the LymPro data on time and had to blame the vendor which someone should have been in contact with sooner than the day before the data was due.

"Patience is a virtue."

Wouldn't you think that JP would know that the lowest price is four cents?

I agree he shouldn't waste time when he doesn't have his facts correct because then he appears misinformed to those individuals that actually do know the facts such as myself.

Aimee in I.R. can be a valuable resource.

52 week low is $24.14. I think we'll see under $29.00 next week.

Just saying!!!

I'm expecting it to bottom in the .05 - .06 range.

I'll have a better idea of what the bottom might be after 9/22.

The bottom is four cents. .12 and .18 are irrelevant. I thought you knew that.

My correspondence with Aimee:

Her response:

Yes that is correct, we can not sell them shares below four cents.
Aimee

Sent from my iPhone


My e-mail to Aimee:

On Sep 9, 2014, at 4:26 PM, WCoastGuynCA@aol.com wrote:


Aimee:

It's been reported that the lowest price Lincoln Park Capital can buy shares is four cents. Is this correct?


Note: Anyone who wants to confirm that LPC can buy shares at four cents can contact aimee.boutcher@amarantus.com to verify it. Of course the market price would have to be at that level.

Individuals who are losing money become very angry and very defensive really fast.

All I do is predict where the share price is headed and present a reasonable basis for it occurring.

I have nothing to do with the company increasing the number of authorized shares by another billion shares. It wasn't my decision to allow LPC to buy shares for as low as four cents. I didn't hire the outside vendor that didn't meet the deadline for the LymPro data. It's not my fault the up-listing will probably not happen until the latter part of next year.

I know who you should blame and it certainly isn't me or anyone else not associated with the company. Hint: His initial are G.C. and he is associated with the company.

9/23 will be very interesting.

p.s. This is my last response to you. You are obviously too emotionally involved in your investment to appreciate the reality of the situation.

"Patience is a virtue."

Best of luck with your investment in $AMBS. I hope you make a lot of money from it.

If that is your definition of those shareholders who didn't take some profits when the share price was above .16 then I agree 100%.

Without substantial news I think the share price could hit the .05-.06 range before the end of the year.

The additional one billion shares will not be well received by the market especially since it appears the planned up-listing won't happen until 1H2015 if then.

Almost everyone who bought and held over the last three months is now at a loss. With so many shares entering the float any increase in the share price due to positive news will not have the same impact that it had three months ago.

Lincoln Park Capital can buy shares as low as four cents so if the share price moves lower any purchase by LPC will involve substantially more shares and additional dilution.

Best of luck to all the $AMBS shareholders. I hope you make a lot of money.

Good for you.

Unfortunately almost everyone who bought shares and held them over the last three months has lost money on their investment. Many of these are new investors some of whom have lost as much as 45% of their investment and are facing further losses over the next three to four weeks.

It's interesting that Gerald refers to the long term investors and ignores those that have gotten burned because of his failure to deliver in previously indicated time frames.

It happens in the land of penny stocks.

$NUGT is at or near a bottom here. The dollar is overvalued and gold is undervalued.

Play the rebound.